37 related articles for article (PubMed ID: 2536292)
1. Comprehensive Evaluation of Multiple Approaches Targeting ABCB1 to Resensitize Docetaxel-Resistant Prostate Cancer Cell Lines.
Linke D; Donix L; Peitzsch C; Erb HHH; Dubrovska A; Pfeifer M; Thomas C; Fuessel S; Erdmann K
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614114
[TBL] [Abstract][Full Text] [Related]
2. Correlation of Technical and Adjunctive Factors with Quantitative Tumor Reduction in Children Undergoing Selective Ophthalmic Artery Infusion Chemotherapy for Retinoblastoma.
Abruzzo T; Abraham K; Karani KB; Geller JI; Vadivelu S; Racadio JM; Zhang B; Correa ZM
AJNR Am J Neuroradiol; 2021 Jan; 42(2):354-361. PubMed ID: 33361377
[TBL] [Abstract][Full Text] [Related]
3. Novel Therapeutic Approaches of Ion Channels and Transporters in Cancer.
Ramírez A; García-Quiroz J; Aguilar-Eslava L; Sánchez-Pérez Y; Camacho J
Rev Physiol Biochem Pharmacol; 2022; 183():45-101. PubMed ID: 32715321
[TBL] [Abstract][Full Text] [Related]
4. Anticancer Effects of Antihypertensive L-Type Calcium Channel Blockers on Chemoresistant Lung Cancer Cells via Autophagy and Apoptosis.
Wong BS; Chiu LY; Tu DG; Sheu GT; Chan TT
Cancer Manag Res; 2020; 12():1913-1927. PubMed ID: 32214849
[TBL] [Abstract][Full Text] [Related]
5. BIRICODAR (VX-710; Incel): an effective chemosensitizer in neuroblastoma.
Yanagisawa T; Newman A; Coley H; Renshaw J; Pinkerton CR; Pritchard-Jones K
Br J Cancer; 1999 Jun; 80(8):1190-6. PubMed ID: 10376971
[TBL] [Abstract][Full Text] [Related]
6. High-dose cyclosporin with etoposide--toxicity and pharmacokinetic interaction in children with solid tumours.
Bisogno G; Cowie F; Boddy A; Thomas HD; Dick G; Pinkerton CR
Br J Cancer; 1998 Jun; 77(12):2304-9. PubMed ID: 9649150
[TBL] [Abstract][Full Text] [Related]
7. Multidrug resistance in pediatric oncology.
Kuttesch JF
Invest New Drugs; 1996; 14(1):55-67. PubMed ID: 8880394
[TBL] [Abstract][Full Text] [Related]
8. Effects of verapamil on the pharmacokinetics and metabolism of epirubicin.
Mross K; Hamm K; Hossfeld DK
Cancer Chemother Pharmacol; 1993; 31(5):369-75. PubMed ID: 8431970
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of racemic verapamil vs R-verapamil on normal and leukemic progenitors.
Visani G; Fogli M; Tosi P; Ottaviani E; Gamberi B; Cenacchi A; Manfroi S; Tura S
Ann Hematol; 1993 Jun; 66(6):273-6. PubMed ID: 8318558
[TBL] [Abstract][Full Text] [Related]
10. Multidrug resistance circumvention by a new triazinoaminopiperidine derivative S9788 in vitro: definition of the optimal schedule and comparison with verapamil.
Julia AM; Roché H; Berlion M; Lucas C; Milano G; Robert J; Bizzari JP; Canal P
Br J Cancer; 1994 May; 69(5):868-74. PubMed ID: 8180016
[TBL] [Abstract][Full Text] [Related]
11. Influence of sequential exposure to R-verapamil or B8509-035 on rhodamine 123 accumulation in human lymphoblastoid cell lines.
Roller E; Klumpp B; Krause J; Eichelbaum M; Schumacher K
Cancer Chemother Pharmacol; 1993; 32(2):151-5. PubMed ID: 8097969
[TBL] [Abstract][Full Text] [Related]
12. Multidrug resistance in cancer chemotherapy.
Patel NH; Rothenberg ML
Invest New Drugs; 1994; 12(1):1-13. PubMed ID: 7960599
[TBL] [Abstract][Full Text] [Related]
13. A phase II study of vinblastine in combination with acrivastine in patients with advanced renal cell carcinoma.
Berlin J; King AC; Tutsch K; Findlay JW; Kohler P; Collier M; Clendeninn NJ; Wilding G
Invest New Drugs; 1994; 12(2):137-41. PubMed ID: 7860231
[TBL] [Abstract][Full Text] [Related]
14. Continuous-infusion verapamil with etoposide in relapsed or resistant paediatric cancers.
Cowie FJ; Pinkerton CR; Phillips M; Dick G; Judson I; McCarthy PT; Flanagan RJ
Br J Cancer; 1995 Apr; 71(4):877-81. PubMed ID: 7710958
[TBL] [Abstract][Full Text] [Related]
15. Effects of verapamil enantiomers and major metabolites on the cytotoxicity of vincristine and daunomycin in human lymphoma cell lines.
Häussermann K; Benz B; Gekeler V; Schumacher K; Eichelbaum M
Eur J Clin Pharmacol; 1991; 40(1):53-9. PubMed ID: 2060546
[TBL] [Abstract][Full Text] [Related]
16. A phase II study of epidoxorubicin in colorectal cancer and the use of cyclosporin-A in an attempt to reverse multidrug resistance.
Verweij J; Herweijer H; Oosterom R; van der Burg ME; Planting AS; Seynaeve C; Stoter G; Nooter K
Br J Cancer; 1991 Aug; 64(2):361-4. PubMed ID: 1892765
[TBL] [Abstract][Full Text] [Related]
17. Multidrug resistance (mdr) genes in human cancer.
Nooter K; Herweijer H
Br J Cancer; 1991 May; 63(5):663-9. PubMed ID: 1674875
[No Abstract] [Full Text] [Related]
18. Clinical trial of continuous infusion verapamil, bolus vinblastine, and continuous infusion VP-16 in drug-resistant pediatric tumors.
Cairo MS; Siegel S; Anas N; Sender L
Cancer Res; 1989 Feb; 49(4):1063-6. PubMed ID: 2536292
[TBL] [Abstract][Full Text] [Related]
19. Phase I study of high-dose continuous intravenous infusion of VP-16 in combination with high-dose melphalan followed by autologous bone marrow transplantation in children with stage IV neuroblastoma.
Valteau-Couanet D; Vassal G; Pondarré C; Bonnay M; Benhamou E; Couanet D; Plantaz D; Hartmann O
Bone Marrow Transplant; 1996 Apr; 17(4):485-9. PubMed ID: 8722343
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
